---
figid: PMC5357773__fimmu-08-00280-g006
figlink: /pmc/articles/PMC5357773/figure/F6/
number: F6
caption: Model for FcγRIIIb signaling to induce neutrophil extracellular trap (NET)
  formation. In human neutrophils (PMN), crosslinking FcγRIIIb results in activation
  of Syk (spleen tyrosine kinase) and TAK1 (transforming growth factor-β-activated
  kinase 1). These kinases lead to activation of PKC (protein kinase C) and the MEK/ERK
  signaling pathway to generate the production of reactive oxygen species via NADPH
  oxidase and to induce NETs formation. The question marks indicate that the mechanism
  for FcγRIIIb-induced Syk activation is not known, and that it is not clear whether
  TAK1 functions upstream of PKC. Model based on Alemán et al. ().
pmcid: PMC5357773
papertitle: Fcγ Receptor Heterogeneity in Leukocyte Functional Responses.
reftext: Carlos Rosales. Front Immunol. 2017;8:280.
pmc_ranked_result_index: '106771'
pathway_score: 0.9559896
filename: fimmu-08-00280-g006.jpg
figtitle: FcGRIIIb signaling to induce neutrophil extracellular trap (NET) formation
year: '2017'
organisms:
- Homo sapiens
ndex: aeee3103-deaf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5357773__fimmu-08-00280-g006.html
  '@type': Dataset
  description: Model for FcγRIIIb signaling to induce neutrophil extracellular trap
    (NET) formation. In human neutrophils (PMN), crosslinking FcγRIIIb results in
    activation of Syk (spleen tyrosine kinase) and TAK1 (transforming growth factor-β-activated
    kinase 1). These kinases lead to activation of PKC (protein kinase C) and the
    MEK/ERK signaling pathway to generate the production of reactive oxygen species
    via NADPH oxidase and to induce NETs formation. The question marks indicate that
    the mechanism for FcγRIIIb-induced Syk activation is not known, and that it is
    not clear whether TAK1 functions upstream of PKC. Model based on Alemán et al.
    ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K2
  - PRKCG
  - PRKCE
  - PRKCH
  - SPINK5
  - PRKCD
  - MAPK3
  - MAP2K1
  - PRKCQ
  - MAPK1
  - PRKD3
  - PRKCA
  - PRKCB
  - PRKCZ
  - SYK
  - PRKCI
  - NR2C2
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: NETS
  symbol: NETS
  source: hgnc_alias_symbol
  hgnc_symbol: SPINK5
  entrez: '11005'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: SyK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
chemicals: []
diseases: []
figid_alias: PMC5357773__F6
redirect_from: /figures/PMC5357773__F6
figtype: Figure
---
